Homology Medicines Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Homology Medicines Inc
TickerQTTB
CIK #0001661998
CUSIP746964105
SectorLife Sciences - Pharmaceutical Preparations
Address45 Wiggins Ave, Bedford, MA 01730
Source [EDGAR]
CIK Filing 2011 - 2025
[0001661998] 10-K
[0001661998] 10-Q
[0001661998] 3
[0001661998] 4
[0001661998] 8-K
[0001661998] D
[0001661998] SC 13D
[0001661998] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
SIO Capital Management LLC Q32 Bio Inc [2025-04-08] 0.0
SIO Capital Management LLC Q32 Bio Inc [2025-02-10] 0.0
Bristol Myers Squibb Co Q32 Bio Inc [2024-11-13] 6.23
Acorn BioVentures LP Q32 Bio Inc [2024-04-04] 6.7
Atlas Venture Fund X LP Q32 Bio Inc [2024-04-01] 7.2
Carlyle Group Inc Q32 Bio Inc [2024-03-29] 9.2
OrbiMed Advisors LLC Q32 Bio Inc [2024-03-28] 18.9
Adar1 Partners LP Homology Medicines Inc [2024-03-14] 0.0
BlackRock Inc Homology Medicines Inc [2022-07-08] 2.9
BlackRock Inc Homology Medicines Inc [2021-02-02] 6.1
Pfizer Inc Homology Medicines Inc [2020-11-19] 0.9
Price T Rowe Associates Inc /MD/ Homology Medicines Inc [2020-02-14] 6.3
RTW Investments LP Homology Medicines Inc [2019-12-30] 8.82
Arch Venture Fund VIII LP Homology Medicines Inc [2019-02-14] 16.2
5AM Ventures IV LP Homology Medicines Inc [2019-02-13] 15.7
FMR LLC Homology Medicines Inc [2019-02-13] 0.0
Novartis Institutes for Biomedical Research Inc Homology Medicines Inc [2019-02-04] 5.3
JPMorgan Chase & Co Homology Medicines Inc [2019-01-10] 5.9
Temasek Holdings Private Ltd Homology Medicines Inc [2018-04-11] 8.6
Flynn James E Homology Medicines Inc [2018-04-06] 6.98
Form 3/4/5 Filer 2011 - 2025
Tzianabos Arthur
Q32 Bio Inc.
Manke Isaac
Kalowski Lee
Laporte Kathleen
Campagna Jason
Grayzel David S
Thistle Mary
Lundberg Sven Ante
Violette Shelia M.
Morrison Jodie Pope
Xu Diyong
Iwicki Mark T
Alloway Paul
Michaud Charles Jr
OrbiMed Capital GP VII LLC
OrbiMed Advisors LLC
Atlas Venture Associates Opportunity II, LP
Atlas Venture Associates Opportunity I, LLC
Atlas Venture Fund X, L.P.
Atlas Venture Opportunity Fund II, L.P.
Atlas Venture Associates X, LLC
Atlas Venture Associates X LP
Atlas Venture Opportunity Fund I, L.P.
Atlas Venture Associates Opportunity II, LLC
Atlas Venture Associates Opportunity I, L.P.
Seymour Albert
Jordan Julie
Gillis Steven
Patterson Matthew R
Poulton Jeffrey V.
Reicin Alise
Smith W Bradford
Blum Michael Lee
Parmar Kush
Gregory Richard J.
Kelly Timothy P
Cohn Gabriel
Rocklage Scott M
5AM Ventures IV, L.P.
Schwab Andrew J.
5AM Co-Investors IV, L.P.
Diekman John D
5AM Partners IV, LLC
Deerfield Mgmt L.P.
Flynn James E
Deerfield Healthcare Innovations Fund, L.P.
Deerfield Mgmt III, L.P.
Deerfield Mgmt HIF, L.P.
Deerfield Management Company LP
Deerfield Partners LP
Deerfield Private Design Fund III, L.P.
Rasty Siyamak
Wheeler Cameron
ARCH Venture Fund VIII, L.P.
Crandell Keith
ARCH Venture Fund VIII Overage, L.P.
ARCH Venture Partners VIII, L.P.
ARCH Venture Partners VIII, LLC
Nelsen Robert
Bybee Clinton
Temasek Life Sciences Private Ltd
V-Sciences Investments Pte Ltd
Fullerton Management Pte Ltd
Temasek Holdings (Private) Ltd
TLS Beta Pte. Ltd.
VV Manager LLC
Vida Ventures, LLC
Novartis Institutes for BioMedical Research, Inc.
Novartis AG
Rock Springs Capital LLC
Rock Springs Capital Master Fund LP
Rock Springs Capital Management LP
Shah Mahendra
Chatterjee Saswati
Form 13F Holdings
Firm Period DFND Voting Shares
OrbiMed Advisors LLC [2025-06-30] SOLE 2,252,987 2,252,987
Atlas Venture Life Science Advisors LLC [2025-06-30] SOLE 2,092,106 2,092,106
Carlyle Group Inc. [2025-06-30] DFND 0 1,102,741
Acorn Capital Advisors LLC [2025-06-30] SOLE 803,425 803,425
Monaco Asset Management SAM [2025-06-30] SOLE 591,937 591,937
Arch Venture Management LLC [2025-06-30] SOLE 0 320,482
Pfizer Inc [2025-06-30] SOLE 277,777 277,777
Vanguard Group Inc [2025-06-30] SOLE 0 267,514
Sanofi [2025-06-30] SOLE 244,083 244,083
BlackRock, Inc. [2025-06-30] SOLE 175,010 178,677
Trustees of Columbia University in the City of New York [2025-06-30] SOLE 133,903 133,903
Millennium Management LLC [2025-06-30] SOLE 130,379 130,379
Renaissance Technologies LLC [2025-06-30] SOLE 77,000 77,000
Goldman Sachs Group Inc [2025-06-30] DFND 63,539 63,539
Geode Capital Management LLC [2025-06-30] DFND 61,599 61,599
Jane Street Group LLC [2025-06-30] DFND 46,635 46,635
FMR LLC [2025-06-30] DFND 39,121 42,439
Acadian Asset Management LLC [2025-06-30] DFND 29,739 29,739
Affinity Asset Advisors LLC [2025-06-30] SOLE 27,777 27,777
State Street Corp [2025-06-30] DFND 26,937 26,937
Northern Trust Corp [2025-06-30] DFND 26,058 26,058
AQR Capital Management LLC [2025-06-30] DFND 26,029 26,029
Morgan Stanley [2025-06-30] DFND 18,509 18,648
Marshall Wace LLP [2025-06-30] OTR 0 16,928
Oppenheimer & Co Inc [2025-06-30] SOLE 13,000 13,000
Susquehanna International Group LLP [2025-06-30] OTR 12,909 12,909
UBS Group AG [2025-06-30] DFND 12,576 12,576
Mariner LLC [2025-06-30] SOLE 0 11,780
Citadel Advisors LLC [2025-06-30] DFND 10,900 10,900
Raymond James Financial Inc [2025-06-30] DFND 0 10,746
Prev | Page 8 | Next
Terms | Privacy | Guide
tony@aum13f.com